Richard McHale - ResMed Insider

ResMed -- USA Stock  

USD 98.80  1.57  1.56%

President ? Respiratory Care

Mr. Richard McHale is President Respiratory Care of the Company. He previously served as the companys chief human resources officer, beginning in November 2013, and joined ResMed in 2011 as director of its United Kingdom business team. Mr. McHale has 25 years experience in the life sciences sector, working primarily in commercial roles within pharmaceutical, biotechnology and medical technology companies. Prior to joining ResMed, he was managing director of UCB Pharmas United Kingdom and Ireland business units. He also served as chair of the European Medicines Group and a member of the Board of Management for the Association of British Pharmaceutical Industry
Age: 52  President Since 2017      
858-836-5000  http://www.resmed.com
McHale holds a master?s degree in coaching psychology from the Metanoia Institute in London.

Richard McHale Latest Insider Activity

Richard McHale over two months ago via Macroaxis 
Sale by Richard McHale of 2000 shares of ResMed

Management Efficiency

The company has Return on Asset of 9.1 % which means that on every $100 spent on asset it made $9.1 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.29 % implying that it generated $15.29 on every 100 dollars invested.
The company has 1.02 B in debt with debt to equity (D/E) ratio of 50.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. ResMed has Current Ratio of 1.26 demonstrating that it may have difficulties to pay its financial commitments when the payables are due.

Similar Executives

Entity Summary

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in USA and traded on New York Stock Exchange. It employs 6000 people.ResMed (RMD) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 6,000 people. ResMed is listed under Medical Equipment category by Fama And French industry classification.

ResMed Leadership Team

John Wareham, Director, MBA
Ronald Taylor, Director
Rob Douglas, President
Christopher Roberts, Director, MBA
Gary Pace, Director, Ph.D
Chris Roberts, Director, MBA
Robert Douglas, COO
Agnes Lee, Director
Carol Burt, Director
Rich Sulpizio, Director
Peter Farrell, Chairman, Ph.D
Jim Hollingshead, President, Ph.D
Brett Sandercock, CFO
Ron Taylor, Director
Don Darkin, President
Jack Wareham, Director
Anne Reiser, President
Karen Drexler, Director
Raj Sodhi, President, MBA
David Pendarvis, Executive
Richard Sulpizio, Director
Michael Farrell, CEO, MBA
Richard McHale, President
Donald Darkin, President

Stock Performance Indicators

Did you try this?

Run Focused Opportunities Now
   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
View All  Next Launch Focused Opportunities

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
few hours ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
few hours ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
few hours ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
few hours ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
few hours ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
few hours ago
Traded for 23.82
Additionally take a look at Your Equity Center. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.